This course aims to provide knowledge of the skills, data, and methodology required to critically evaluate new medical technologies in order to meet financial investment as well as regulatory compliance objectives, such as FDA approval. The course is designed to provide an introduction to the analytic tool kit needed to critically evaluate new medical technology, such as cost-benefit analysis, cost effectiveness analysis as well as other decision-analytic models and markov-models.

This course prepares students to analyze large health care databases with a focus on advanced applications with health insurance claims data. The course is designed to be a STEM offering with the use of statistical programming languages including R, Tableau, and SAS. This course is designed to appeal to students with an interest in developing data science as a core skill and already have knowledge of some programming tools, and experience with data manipulation in Excel, SQL, or Access. The course utilizes a novel synthetic health insurance claims database representing 300 million covered lives of the major private and publicly insured insured populations in the United States. Major topics include market sizing, actuarial projection, quality of care metrics, and national health account calculation.

Survey of trillion dollar medical industry. Physician/hospital services, insurance, pharmaceuticals, medical devices, information technology. Scale, interactions, inter-relationships, market opportunities, barriers. prereq: MBA student

Business/policy issues specific to pharmaceutical industry. Interdisciplinary perspectives, active involvement by industry leaders.

This course will survey fundamental healthcare laws that apply to a wide variety of healthcare businesses, and will examine their impact on business strategy and operations. The goal is to enable current and prospective managers and leaders in the healthcare space to understand compliance requirements and how healthcare law impacts business strategy and decisions. In the end, healthcare law can be a competitive advantage. In addition, the course will address key current healthcare policy challenges and how these impact business environment and strategy.

Theoretical/conceptual base for health care information technology. Applications of current/developing health IT. Approaches to evaluate effectiveness of health IT systems. Information technology, computer technology, and data structures commonly found in health care information systems. Information system design/evaluation. prereq: MBA student

This course, with the insight of industry leaders, addresses public-private sector interactions and the business, public policy, regulatory, and technology management issues that concern medical device and biotechnology companies.

Discussion and analysis of current topics and developments in the medical industry.

Overview of medical vocabulary/physiology of major body systems. Understanding current clinical practice. Market opportunities of major body systems, Medical technology innovation.

Understand stakeholders that impact healthcare delivery including providers, payers, employers and patients and how they are trying to transform this unique value chain to improve care while reducing cost.

Global version of medical industry leadership institute valuation lab. Assess value of proprietary inventions.

The motivation for developing this course is the widespread and growing recognition of the need to design and sustain reliable, responsive, resilient, and responsible supply chains to enable the delivery of high quality, high volume, and affordable physical and mental health care equitably in both developed and developing countries. The course advances an end-to-end, supply chain?centric view of the health care and medical devices sector ? i.e., linking the development of care to the delivery of care: ?from bench to bed.? The course highlights the interdependencies between organizations on the upstream (e.g., medical devices, pharma, and biotech firms) and downstream (e.g., hospitals and clinics) of the healthcare supply chain. Topics addressed include: managing supply chain risks with rapid growth in adverse events and recalls related to medical devices and drugs; and reducing the disparities in health care delivery in underserved communities around the world. Implications of scientific and technological advancements ? specifically, precision medicine, surgical robots, mobile & wearable devices, telemedicine and IoT (Internet of Technology) ? for designing and sustaining health care supply chains will be a theme that will run through the entire course. We will closely follow the developments related to COVID-19 pandemic throughout the duration of the course. In every class session, we will make a concerted effort to explore the topic of the session and its relevance to understanding and addressing COVID-19 related issues at the local, state, national and global levels -- e.g., understanding the roles of the Minnesota Department of Health (MDH), Center for Disease Control (CDC), Food and Drug Administration (FDA), Federal Emergency Management Agency (FEMA) and the World Health Organization (WHO).